17 -2 (26/1) 2019 — Z.Y. Xalimova, D.U.Uralova, — SYNDROME HYPERPROLACTINEMIA IN FEMALE AND MALE

SYNDROME HYPERPROLACTINEMIA IN FEMALE AND MALE

Z.Y. Xalimova, 1Tashkent Pediatric Medical Institute, 2RSSPMC of Endocrynology, 3Tashkent Medical Academy.

D.U.Uralova, 1Tashkent Pediatric Medical Institute, 2RSSPMC of Endocrynology, 3Tashkent Medical Academy.

M.S. Safarova, 1Tashkent Pediatric Medical Institute, 2RSSPMC of Endocrynology, 3Tashkent Medical Academy.

 X.I. Uralov1Tashkent Pediatric Medical Institute, 2RSSPMC of Endocrynology, 3Tashkent Medical Academy.

Resume,

Article dedicated important questions of etiology, pathogenesis, clinical manifestation, diagnostics and treatment of hyperprolactinemia

Keywords: Prolactin, circadian rhythm, hypophysis, hypothalamus, hyperprolactinemia, hypogonadism.

First page

67

Last page

71

For citation: Z.Y. Xalimova, D.U.Uralova, M.S. Safarova, X.I. Uralov Syndrome hyperprolactinemia in female and male//New Day in Medicine 2(26)2019 67-71 https://cutt.ly/WbvU1a5

List of References

  1. Дедов И.И., Мельниченко Г.А. Эвдокриналогия национальное /Руководство Краткое Издание. 2013. 615-618.
  2. Дедов И.И., Дедов В.И. Биоритмы юрмонов /М. Медицина 1992. 75-79.
  3. Мельниченко Г.А., Длеранова Л.К., Пигарова Е.А., Воротни­кова С.Ю., Рожинская Л.Я., Дедов И.И. Федеральные кли­нические рекомендации по гиперпролактинемии: клиника, диагностика, дифференциальная диагностика и методы лече­ния. //Проблемы Эндокринологии 2013., 6, 19-26.
  4. Мохорт Т.В., Сафина М.Р. Синдром гиперпролактинемии: современные подходы к диагностике и. течению. Репродук­тивное здоровье. //Восточная Европа 2012. №4 (22) 130-141.
  5. Российская Ассоциация Эндокринологов ФГБУ Эндокрино­логический научный Центр Минздрава России. Федеральные клинические рекомевдации по гиперпролактинемии: клиника, диагностика, дифференциалыная диагностика и методы лечния. /М.Медицина. 2015. 6-20.
  6. Серов В.Н., Прилепская В.Н., Овсянникова Т.В. Гинекологическая эндокриналогия. /М.Медицина 2004. 50-70, 97-125.
  7. Asa SL, Ezzat S. The pathogenesis of pituitary tumours. //Nat Rev Cancer 2002; 2:836-49. [PubMed].
  8. Са1агде CA, Ellingrod VL, Acion L, Miller DD, Moline J, Tansey MJ, Schlechte JA 2009 Variants of the Dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents. //Pharmacogenet Genomics 19:373-382.
  9. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Scalon M, Sobrinho LG, Wass JA, Giustina A 2006 Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. //Clin Endocrinol (Oxf) 65: 265-273.
  10. Donadio F., Barbieri A., Angioni R., Mantovani G., Beck- Peccoz P., Spada A., Lania A.G. 2007 Patients with macroprolactinemia: clinical and radiological features. //Eur J Clin Invest 37: 552-557.
  11. Gonzalez JG, Elizondo G, Saldivar D, Nanez H, Todd LE, Villareal JZ 1988 Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. //Am J Med 85:217-220.
  12. Hattori N. 2003 Macroprolactinemia: a new cause of hyperprolactinemia. //J Pharmacol Sci 92: 171-177.
  13. Jameson J.L. Harrison’s Endocrinology. /Great Britain 2010. 29­34.
  14. Kaltsas GA, Nomikos P, Kontogeorgos G, Buchfelder M, Grossman AB 2005 Clinical review: diagnosis and management of pituitary carcinomas. //J Clin Endocrinol Metab 90:3089­3099.
  15. Kars M, Roelfsema F, Romijn JA, Pereira AM 2006 Malignant Prolactinoma: case report and review of the literature. //Eur J Endocrinol 155:523-534.
  16. Kars M., Souverein P.C., Herings R.M., Romijn J.A., Vandenbrouche J.P., de Boer A., Dekkers O.M. 2009 Estimated age- and sex-specific incidence and prevalence of dopamine agonist-treated hyperprolactinemia. //J Clin Endocrinol Metab 94: 2729-2734.
  17. Kearns A.E, Goff DC, Hayden D.L, Daniels G.H 2000 Risperidone-associated hyperprolactinemia. //Endocr Pract 6:425-429.
  18. Mancini T, Casanueva F.F, Giustina A. 2008 Hyperprolactinemia and prolactinomas. //Endocrinol Metab Clin North Am: 37:67­99.
  19. McKenna T.J. 2009 should macroprolactin be measured in all hyperprolactinaemic sera? //Clin Endocrinol (Oxf) 71: 466­467.
  20. Melmed Sh., Feli pe F. Casanueva, Andrew R. Hoffman, David L. Kleinberg, Victor M. Montori, Janet A. Schlechte, and John A. H. Wass. Diagnosis and Treatment of Hyperprolactinemia: // an Endocrine Society Clinical Practice Guideline. Endocrine Society 2011. 273-288.

file

download